Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Onc real “ value” can be realized, only by science

<< Previous

Bullboard Posts

Next >>

Comment by HCallahann44on Nov 02, 2022 9:16am

124 Views

Post# 35065737

RE:Onc real “ value” can be realized, only by science

Canada....you were saying the EXACT same thing five years ago.....how do you explain the complete lack of price movement in the run up to next week???? HArdly any volume either. There might be a small spike in the price....i have my sell order in....then it will return to 1.30.....i am out if it spikes....and will only look back next year to see you putting out the same old BS

<< Previous

Bullboard Posts

Next >>

Quest Diagnostics to acquire LifeLabs from OMERS for C$1.35 billion